Evaluating the efficacy of mirtazapine versus sertraline on depression symptoms in patients undergoing hemodialysis
Phase 3
Not yet recruiting
- Conditions
- Depression.Other depressive episodesF32.8
- Registration Number
- IRCT20120215009014N445
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Age of 18 to 5 years
Undergoing hemodialysis for at least 6 months
Being literate
Suffering from depression
Exclusion Criteria
Pregnancy or breastfeeding
Receiving anti-depressant and anti-anxiety medication in the last 3 months
Liver failure
Use of drugs or alcohol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score. Timepoint: In weeks 4, 8, and 12 after the treatment. Method of measurement: Using the Beck Inventory Questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of life score. Timepoint: After week 12. Method of measurement: Using Global Quality of Life Scale.;Serum albumin level. Timepoint: After week 12. Method of measurement: By using laboratory test.;Percentage of weight gain. Timepoint: After week 12. Method of measurement: By using weights.